Have a feature idea you'd love to see implemented?
Let us know!
VINC Vincerx Pharma Inc
Price (delayed)
$0.256
Market cap
$8.59M
P/E Ratio
N/A
Dividend/share
N/A
EPS
-$1.03
Enterprise value
$7.2M
Vincerx Pharma (Vincerx) is a recently formed clinical-stage life sciences company focused on leveraging its extensive development and oncology expertise to advance new therapies intended to address unmet medical needs
Highlights
VINC's EPS has soared by 53% year-on-year and by 20% since the previous quarter
The company's net income rose by 42% YoY and by 4.1% QoQ
The company's equity fell by 42% YoY and by 41% QoQ
The quick ratio has declined by 33% since the previous quarter and by 5% year-on-year
Key stats
What are the main financial stats of VINC
Market
Valuations
Earnings
Shares outstanding
33.56M
Market cap
$8.59M
Enterprise value
$7.2M
Price to earnings (P/E)
N/A
Price to book (P/B)
0.83
Price to sales (P/S)
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
Revenue
$0
EBIT
-$27.03M
EBITDA
-$25.96M
Free cash flow
-$27.97M
Per share
Balance sheet
Liquidity
EPS
-$1.03
Free cash flow per share
-$0.61
Book value per share
$0.31
Revenue per share
$0
TBVPS
$0.33
Total assets
$14.95M
Total liabilities
$5.84M
Debt
$1.64M
Equity
$9.11M
Working capital
$6.32M
Debt to equity
0.18
Current ratio
2.17
Quick ratio
2.35
Net debt/EBITDA
0.05
Margins
Efficiency
Dividend
EBITDA margin
N/A
Gross margin
N/A
Net margin
N/A
Operating margin
N/A
Return on assets
-164.4%
Return on equity
-307.5%
Return on invested capital
-600.9%
Return on capital employed
-283.8%
Return on sales
N/A
Dividend yield
N/A
DPS
N/A
Payout ratio
N/A
VINC stock price
How has the Vincerx Pharma stock price performed over time
Intraday
-7.11%
1 week
-14.58%
1 month
-32.29%
1 year
-62.02%
YTD
-78.31%
QTD
-64.25%
Financial performance
How have Vincerx Pharma's revenue and profit performed over time
Revenue
$0
Gross profit
$0
Operating income
-$28.17M
Net income
-$27.03M
Gross margin
N/A
Net margin
N/A
VINC's operating income is up by 44% year-on-year and by 6% since the previous quarter
The company's net income rose by 42% YoY and by 4.1% QoQ
Growth
What is Vincerx Pharma's growth rate over time
Valuation
What is Vincerx Pharma stock price valuation
P/E
N/A
P/B
0.83
P/S
N/A
EV/EBIT
N/A
EV/EBITDA
N/A
EV/Sales
N/A
VINC's EPS has soared by 53% year-on-year and by 20% since the previous quarter
The stock's P/B is 83% below its 5-year quarterly average of 4.8
The company's equity fell by 42% YoY and by 41% QoQ
Efficiency
How efficient is Vincerx Pharma business performance
VINC's return on equity has dropped by 102% year-on-year and by 14% since the previous quarter
The ROA has contracted by 49% YoY and by 12% from the previous quarter
Vincerx Pharma's return on invested capital has increased by 21% QoQ
Dividends
What is VINC's dividend
DPS
N/A
Dividend yield
N/A
Payout ratio
N/A
There are no recent dividends present for VINC.
Financial health
How did Vincerx Pharma financials performed over time
The total assets is 156% more than the total liabilities
The company's total liabilities fell by 45% YoY and by 3.9% QoQ
The total assets has decreased by 43% YoY and by 31% from the previous quarter
The debt is 82% less than the equity
The company's equity fell by 42% YoY and by 41% QoQ
The debt has contracted by 41% YoY and by 15% from the previous quarter
All financial data is based on trailing twelve months (TTM) periods - updated quarterly, unless otherwise
specified. Data from 
and Sharadar.